Hepatitis C therapeutics: current status and emerging strategies

Area of Science:

• Hepatology and Virology
• Infectious Diseases
• Drug Discovery

Background:

• Chronic hepatitis C virus (HCV) infection represents a significant and growing global epidemic.
• Developing effective antiviral treatments for HCV is hindered by a lack of suitable animal and cell culture models for viral propagation and study.

Purpose of the Study:

• To review the challenges and progress in developing effective antiviral therapeutics for chronic hepatitis C virus (HCV) infection.
• To highlight the need for combination approaches and novel strategies, including host-targeting drug discovery, for successful HCV intervention.

Main Methods:

• Review of current research on HCV antiviral therapeutics.
• Analysis of obstacles in HCV research, including inadequate animal and tissue-culture models.
• Exploration of therapeutic strategies, including viral replicative element inhibitors, immune modulators, and host-targeting agents.

Main Results:

• Despite significant challenges, progress has been made in developing various classes of HCV therapeutics.
• Existing obstacles, such as the lack of adequate models, continue to impede research and development.
• Combination therapy and novel approaches targeting host factors are promising avenues for future treatment.

Conclusions:

• Successful treatment of chronic hepatitis C virus (HCV) infection will likely necessitate multifaceted therapeutic strategies.
• Continued research into inhibitors of viral replication, immune modulation, and host-directed therapies is crucial.
• Advancements in drug discovery targeting host factors offer new hope for combating the HCV epidemic.